Mediclinic International

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Monday, February 27, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.
  • (c) Name of offeror/offeree in relation to whose relevant securities this form relates:
    (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
    (e) Date position held/dealing undertaken:
    For an opening position disclosure, state the latest practicable date prior to the disclosure
    (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
  • If it is a cash offer or possible cash offer, state “N/A”
    If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Saturday, February 25, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Thursday, February 23, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Wednesday, February 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Wednesday, February 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Wednesday, February 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Wednesday, February 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Wednesday, February 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Wednesday, February 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Retrieved on: 
Wednesday, February 22, 2023

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.